DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Faculty of Arts and Sciences
  3. FAS Theses and Dissertations
  4. Studying the tissue-specificity of cancer driver genes through KRAS and genetic dependency screens.

Studying the tissue-specificity of cancer driver genes through KRAS and genetic dependency screens.

Open/View files
JHC_PhD_Dissertation_with-DAC.pdf (35.7 MB)
Date
January 9, 2023
Author(s)
Cook, Joshua Herman
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Cook, Joshua Herman. 2022. Studying the tissue-specificity of cancer driver genes through KRAS and genetic dependency screens.. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.
Abstract
Cancer is a deadly disease, annually killing millions of people world-wide. Understanding the origin and progression of cancer are essential for designing efficacious treatments. While much is known about the shared factors of different types of cancer, it is becoming more evident that the cell-of-origin is the primary determinant of a tumor’s genetic and phenotypic characteristics. As such, many genes are frequently mutated in some cancer types, but not others, often with vast differences between anatomically related cancers. We hypothesize that most cancer-driving genes are tissue-specific because their effects are dependent upon the preexisting circuitry of the nor- mal cell. The KRAS proto-oncogene is an exemplar of this behavior. KRAS is frequently mu- tated in several cancer types – namely colorectal, lung, and pancreatic adenocarcinomas and multiple myeloma – but rarely in most others. Further, the types of mutations acquired in the KRAS gene are tissue-specific, likely due to the differences in how their biochemical properties interact with the distinct cellular environments to drive cancer. In the first of three studies com- piled here, a thorough characterization of the genetic contexts of the different KRAS mutations in these four cancer types was conducted using thousands of human tumor samples via an array of computational methods including predicting the most influential mutagenic forces and dis- covering mutation- and tissue-specific comutation networks. The following report statistically estimated the effects of mutant Kras (the homologous gene in the mouse, Mus musculus) on cell proliferation rates in ten tissues of genetically engineered mice to forward our understanding of the impact of oncogenic KRas signaling in different tissues. The final study explored the tissue- specificity of cancer genes by statistically modeling genome-wide CRISPR/Cas9 loss-of-function screens in a diverse array of cancer cell lines, identifying patterns of genetic dependency associ- ated with cancer type. Each of these efforts leverages a distinct strategy for the investigation of tissue-specificity of cancer genes to reveal unique biological insights.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37374557
Subjects

cancer

computational biology...

CRISPR

genetics

KRAS

tissue-specificity

Biology

Collection
FAS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.